Introduction
============

Pancreatic cancer is a malignancy of the pancreas, which is associated with a poor prognosis ([@b1-etm-0-0-8991],[@b2-etm-0-0-8991]), and the morbidity and mortality rates associated with pancreatic cancer have increased globally in recent years ([@b3-etm-0-0-8991]). Currently, surgery is the only possible cure for pancreatic cancer, however, due to the high degree of malignancy, surgical resection rates are low, with unsatisfactory treatment efficacies ([@b6-etm-0-0-8991],[@b7-etm-0-0-8991]). Therefore, the identification of a novel means for early diagnosis and effective treatment for pancreatic cancer is urgently required. A current lack of knowledge regarding the exact molecular mechanism(s) of pancreatic cancer progression reduces the possibility of early diagnosis and timely treatment ([@b8-etm-0-0-8991],[@b9-etm-0-0-8991]). Therefore, the identification of effective biomarkers to improve understanding of the possible pathogenesis of pancreatic cancer is an urgent requirement.

It is well established that microRNAs (miRNAs) are key components of the non-coding RNA family that are capable of extensively regulating gene expression ([@b10-etm-0-0-8991]). The mature miRNAs are derived from their precursors, either generated from spliceosomes or transcribed from the genome ([@b13-etm-0-0-8991]). Previously published studies have confirmed that miRNAs are abnormally expressed in a variety of malignancies, and function either as oncogenes or as tumor suppressors ([@b14-etm-0-0-8991]). miRNAs exhibit the characteristics of high tissue speciﬁcity and stability, with altered expression patterns during tumor development ([@b17-etm-0-0-8991]). Therefore, the potential of miRNAs in the diagnosis of a variety of cancer types may provide researchers with a means to identify and characterize potential biomarkers.

In the present study, data were accessed from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to explore key miRNAs in pancreatic cancer. Comprehensive bioinformatics analysis was used to identify differentially expressed miRNAs (DE-miRNAs). The target genes of prognostic DE-miRNAs were predicted. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were subsequently performed to analyze the functional enrichment of the gene set, and to identify significant pathways that are associated with the target genes. The present study aimed to investigate the involvement of miRNAs critical to pancreatic cancer progression, and to seek a means of improved disease diagnosis.

Materials and methods
=====================

### Data processing and identification of DE-miRNAs

The miRNA sequencing data were downloaded from FireBrowse (version 0.4.13; <http://firebrowse.org/>), which is a data integration database associated with the TCGA database. The data were processed using R language (version 3.4.4; <https://www.r-project.org/>) and normalized by log~2~ transformation. miRNAs that were differentially expressed between pancreatic cancer and healthy tissues were analyzed using the Limma package in R language with the criteria of \|log2FC (fold change)\|\>1.0 and P\<0.05. Results are presented in volcano plots, which were plotted using GraphPad prism.v.5 (GraphPad Software, Inc.), and in heat maps using the open source markup language, HEML ([@b20-etm-0-0-8991]). The gene expression profile (GSE62452) and miRNA expression profile (GSE43796) ([@b21-etm-0-0-8991],[@b22-etm-0-0-8991]) were downloaded from the GEO database (<https://www.ncbi.nlm.nih.gov/geo/>). A total of 31 samples were identified in GSE43796, including 26 pancreatic cancer samples and 5 healthy samples. The GSE43796 data were collected based on the GPL15159 platform Agilent-031181 Unrestricted_Human_miRNA_V16.0_Microarray 030840 (probe name version). The GSE62452 dataset containing 130 samples, including 69 tumor tissues and 61 adjacent tissues, were collected based on the GPL6244 platform (HuGene-1_0-st) Affymetrix Human Gene 1.0 ST Array \[transcript (gene) version\]. Profiles were analyzed using the GEO2R online tool (<http://www.ncbi.nlm.nih.gov/geo/geo2r/>).

### Overall survival (OS) analysis and target gene prediction

OS analyses were evaluated using the online tool, OncoLnc ([@b23-etm-0-0-8991]), which links TCGA survival data to the expression of mRNA, miRNA or long non-coding RNA (lncRNA). miRNAs or genes were identified if they were significantly associated with OS. Target genes were predicted using the online analysis tools, TargetScan (<http://www.targetscan.org/>) ([@b24-etm-0-0-8991]) and DIANA-mT (<http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=mrmicrot/index>) ([@b25-etm-0-0-8991],[@b26-etm-0-0-8991]). To further enhance the accuracy of the bioinformatics analysis, Venn diagrams were used to identify overlapping target genes.

### Functional enrichment analyses

KEGG pathway and GO enrichment analyses were performed for the functional annotation and pathway analyses, to identify the biological processes, cellular components, molecular functions and biological pathways that the genes were significantly enriched in. The results were visualized using ClueGO, which is one of the apps in Cytoscape ([@b27-etm-0-0-8991]). A gene count ≥3 was set as the cut-off criterion.

### Gene expression comparison

The Human Protein Atlas (version 15.0; <https://www.proteinatlas.org>) ([@b28-etm-0-0-8991]), an open platform to provide large amounts of transcriptomics and proteomics data of all 24,000 human proteins, is composed of a Tissue Atlas, Cell Atlas, and Pathology Atlas. Immunohistochemistry results (<https://v15.proteinatlas.org/ENSG00000105810-CDK6/tissue/pancreas>; <https://v15.proteinatlas.org/ENSG00000105810-CDK6/cancer/tissue/pancreatic+cancer>; <https://v15.proteinatlas.org/ENSG00000171848-RRM2/tissue/pancreas>; and <https://v15.proteinatlas.org/ENSG00000171848-RRM2/cancer/tissue/pancreatic+cancer>) were obtained from this database to make comparisons between healthy pancreatic tissues and pancreatic tumor tissues.

Results
=======

### Overall presentation of the entire analytical process

The Limma package in R language was used to analyze the miRNA sequencing data from the TCGA database to identify the DE-miRNAs. To increase the accuracy of the results, two microarrays were downloaded from the GEO database during the analysis. These results demonstrated that hsa-miR-3613-5p may be the most reliable prognostic DE-miRNA. The target genes of hsa-miR-3613-5p were predominantly enriched in 20 KEGG pathways, and the p53 signaling pathway was the main focus in the final analysis. Furthermore, survival analysis of genes in the p53 signaling pathway was also performed, and only the genes for cyclin-dependent kinase 6 (CDK6) and ribonucleoside-diphosphate reductase subunit M2 (RRM2) exhibited prognostic value. A flow-chart of the entire analysis is presented in [Fig. 1](#f1-etm-0-0-8991){ref-type="fig"}.

### Identification of DE-miRNAs in miRNA sequencing data and OS analysis

According to the criteria of \|log2FC\|\>1.0 and P\<0.05, a total of 23 DE-miRNAs in miRNA sequencing data were identified, including four upregulated (hsa-miR-892b, hsa-miR-194-2, hsa-miR-200a and hsa-miR-194-1) and 19 downregulated (hsa-miR-424, hsa-miR-191, hsa-miR-484, hsa-miR-142, hsa-miR-15b, hsa-miR-450a-1, hsa-miR-423, hsa-miR-126, hsa-miR-505, hsa-miR-16-1, hsa-miR-342, hsa-miR-130a, hsa-miR-3613, hsa-miR-450a-2, hsa-miR-26b, hsa-miR-451, hsa-miR-19b-2, hsa-miR-106a and hsa-miR-503) miRNAs ([Table I](#tI-etm-0-0-8991){ref-type="table"}). The results are also presented as a volcano plot and heat-map ([Fig. 2](#f2-etm-0-0-8991){ref-type="fig"}). To identify the miRNAs that could potentially be associated with OS of patients with pancreatic cancer, the online tool OncoLnc was used to access TCGA survival data to evaluate the association between miRNA expression and patient survival. Two miRNAs were identified that may be associated with OS, with P-values and log-rank values of P\<0.05 ([Fig. 3](#f3-etm-0-0-8991){ref-type="fig"}). These were hsa-miR-126-5p and hsa-miR-3613-5p, which are highlighted in the volcano plot ([Fig. 2](#f2-etm-0-0-8991){ref-type="fig"}).

### Target gene prediction

Subsequently, datasets associated with miRNA and pancreatic cancer were searched in the GEO database, and the following data were selected: i) \>30 samples; ii) non-coding RNA profiles; and iii) the period between January 1, 2013 and December 31, 2018. GSE43796 from the GEO database was accessed, and the GEO2R online tool was used to obtain the DE-miRNAs. The top 250 miRNAs were thereby identified ([Table II](#tII-etm-0-0-8991){ref-type="table"}), and the two above-mentioned prognostic miRNAs intersected, leaving only hsa-miR-3613-5p. The association between hsa-miR-3613 and clinical features was evaluated in patients with breast cancer ([Table SI](#SD1-etm-0-0-8991){ref-type="supplementary-material"}). The results indicated that hsa-miR-3613 was significantly associated with clinical stage (P=0.034) and histologic type (P=0.002). Target genes of hsa-miR-3613-5p were predicted using the TargetScan and DIANA-MT online analysis tools. As a result of this analysis, a total of 380 overlapping genes of hsa-miR-3613-5p were identified ([Fig. 4](#f4-etm-0-0-8991){ref-type="fig"}).

### KEGG pathway and GO enrichment analyses of target genes

To elucidate the biological function of overlapping genes, enrichment analyses were performed using ClueGO. The results obtained indicated that genes were predominantly enriched in 20 KEGG pathways, including the tissue growth factor-β, p53 and glioma signaling pathways ([Fig. 5A](#f5-etm-0-0-8991){ref-type="fig"}). The GO biological process terms were predominantly enriched in 'central nervous system development' ([Fig. 5B](#f5-etm-0-0-8991){ref-type="fig"}). To increase the accuracy, one further microarray (GSE62452) from the GEO database was also accessed. The following screens were selected: i) \>30 samples; ii) expression profiles; and iii) the period between January 1, 2013 and December 31, 2018. The GEO2R online tool was applied to explore the differentially expressed genes, and functional analyses of the top 250 genes ([Table SII](#SD2-etm-0-0-8991){ref-type="supplementary-material"}) were performed. The p53 signaling pathway was also identified in the KEGG pathway ([Fig. 6](#f6-etm-0-0-8991){ref-type="fig"}).

### Survival analysis and prognostic gene expression of the p53 signaling pathway

An OS analysis of the genes in the p53 signaling pathway was performed. The results obtained indicated that only the CDK6 and RRM2 genes were associated with OS ([Fig. 7A](#f7-etm-0-0-8991){ref-type="fig"}). Subsequently, the Human Protein Atlas was queried to obtain the immunohistochemistry results of CDK6 and RRM2 gene expression in healthy and cancer tissues ([Fig. 7B](#f7-etm-0-0-8991){ref-type="fig"}). All the results obtained were in agreement that the two genes are highly expressed in tumors, with poor prognosis.

Discussion
==========

Pancreatic cancer is an aggressively malignant digestive tract tumor with a poor prognosis ([@b29-etm-0-0-8991]). The high mortality rate is due to the lack of early detection methods, and an inability to successfully treat patients once they are diagnosed ([@b32-etm-0-0-8991]). Understanding the molecular mechanism of pancreatic cancer progression is of critical importance to improve the diagnosis and treatment of this disease ([@b8-etm-0-0-8991],[@b9-etm-0-0-8991],[@b33-etm-0-0-8991]). Currently, microarrays and high-throughput sequencing analyses have provided us with the expression of thousands of genes in the human genome, and numerous studies have already enabled certain predictions to be made using these data ([@b34-etm-0-0-8991]). The aim is to identify novel targets through such techniques, in order to guide the treatment of pancreatic cancer and improve the efficiency of early diagnosis.

The advent of miRNA research has opened up novel avenues for understanding the post-transcriptional level of gene regulation. The discovery of dysregulated miRNAs in a variety of cancer types has led numerous researchers to study the use of miRNAs as potential biomarkers for early detection, as well as therapeutic agents for the treatment of cancer ([@b11-etm-0-0-8991]). miRNAs are short (19-24 nucleotides) non-coding RNA molecules, which have emerged as promising prognostic, diagnostic and therapeutic tools that may be targeted in the fight against pancreatic cancer ([@b37-etm-0-0-8991]).

In the present study, the miRNA sequencing profiles of 185 pancreatic tumor samples from the TCGA database have been presented. GEO datasets were obtained through a reading of the literature to explore which one would be of the greatest benefit for analysis. The most recent datasets were selected and contained \>30 samples. In the majority of recently published studies, the TCGA and GEO databases have usually been selected to expand the sample range at the beginning of the process of screening data, and other data to accurately quantify the results in subsequent analyses have not subsequently been introduced. However, the present study factored in a novel approach: The continuous introduction of GEO datasets to narrow the scope of the filter, in an attempt to render the results more accurate.

By retrieving literature in PubMed, a total of 14 articles were identified that related of hsa-miR-3613-5p, 6 of which exhibited meaningful results. hsa-miR-3613 was a newly identified miRNA, which has been found to be related to gastric cancer ([@b41-etm-0-0-8991]). Chen *et al* ([@b42-etm-0-0-8991]) demonstrated that hsa-miR-3613 is upregulated in drug-resistant breast cancer cell lines through Affymetrix GeneChip miRNA 4.0 array. However, the experiments suggested that it was not able to serve as a potential source for biomarker detection or as an optimal chemotherapeutic choice for patients with breast cancer. Hsa-miR-3613 was revealed in a study by Chong *et al* ([@b43-etm-0-0-8991]) to be one of the most markedly downregulated miRNAs in recurrent epithelial ovarian cancer (EOC), and may be regarded as a biomarker for the prediction of recurrence in EOC. Castro-Magdonel *et al* ([@b44-etm-0-0-8991]) demonstrated that the presence of hsa-miR-3613 is critical for tumor suppression in retinoblastoma. In addition, a further study in the published literature has revealed that hsa-miR-3613 may be associated with leukemia/small lymphocytic lymphoma ([@b45-etm-0-0-8991]). Hsa-miR-3613 was also demonstrated to be highly expressed in gluteofemoral compared with subcutaneous adipocytes ([@b46-etm-0-0-8991]). To the best of our knowledge, however, no articles have been published that have explored the association between hsa-miR-3613 and pancreatic cancer. Therefore, the present study aimed to investigate this association via high-throughput sequencing analyses.

In addition, genes located downstream of hsa-miR-3613 were also analyzed. The two most recently updated target prediction databases were selected to predict the target(s) of hsa-miR-3613, and KEGG and GO analyses of the target genes were performed to probe for points of intersection.

Previously published studies have revealed the p53 signaling pathway is an important pathway that is closely associated with cancer development ([@b47-etm-0-0-8991]), and mutations in tumor protein 53 (TP53) elicited changes in the expression of numerous other genes ([@b51-etm-0-0-8991]). Two reviews related to pancreatic cancer attracted attention. Makohon-Moore and Iacobuzio-Donahue ([@b54-etm-0-0-8991]) reported that genomic features are closely associated with the pathogenesis of pancreatic cancer, and TP53 undergoes somatic mutations in up to 85% of pancreatic cancers. Another review, written by Rachagani *et al* ([@b37-etm-0-0-8991]), summarized the relationship between miRNAs and tumor suppressor genes (including p53, p16 and SMAD4) in the pathogenesis, diagnosis and therapy of pancreatic cancer. This study concluded that p53 not only has the potential to regulate miRNA expression, but in turn miRNA can also regulate p53 expression. Additionally, the prognostic value of genes in the p53 signaling pathway were evaluated during the current analysis, revealing that the genes for CDK6 and RRM2 are closely associated with prognostic value.

Taken together, through comprehensive bioinformatics analysis, the results presented in the current study identified a prognostic miRNA involved in the progression of pancreatic cancer. These findings may lead to the identification of a number of key miRNAs, genes and pathways for future investigation into the mechanisms and biomarkers of pancreatic cancer. However, the present study did have certain limitations. The main limitation of the present study was due to the retrospective nature of the analysis. At the same time, the small sample size reduced the statistical power, and the limited number of samples expressing hsa-miR-3613 should also be considered as a limiting factor in data analysis. In addition, the data presented in the current study could not fully explain why hsa-miR-3613 was expressed at a high level in pancreatic cancer and resulted in an improved overall prognosis. Further studies using cancer cell lines and animal models should be undertaken in the future to gain additional mechanistic insight into the implications of hsa-miR-3613 expression in disease progression.
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![Flow chart of the entire article analysis. The present study comprised several procedures; namely GEO-based verification, TCGA-based data aggregation of miRNA-seq, and multiple bioinformatics analyses. GEO, Gene Expression Omnibus; TCGA, The Cancer Genome Atlas; miRNA, microRNA; DE, differentially expressed; KEGG, Kyoto Encyclopedia of Genes and Genomes; CDK6, cyclin-dependent kinase 6; RRM2, ribonucleoside-diphosphate reductase subunit M2.](etm-20-03-2705-g00){#f1-etm-0-0-8991}

![Volcano plot and heat-map of differentially expressed miRNAs. (A) Red dots indicated upregulated miRNAs, whereas the green dots indicated downregulated miRNAs. The cut-off criteria were \|log2FC\|\>1.0 and P\<0.05. Prognostic miRNAs are indicated in this Figure by the inverted triangles. (B) Heat-map of the differentially expressed miRNAs. According to the criteria of \|log2FC\|\>1.0 and P\<0.05, a total of 23 DE-miRNAs in miRNA sequencing data were identified, including 4 upregulated and 19 downregulated miRNAs. There are 183 samples, of which 179 are tumor and 4 are healthy. Pink coloration denotes miRNA upregulation, whereas purple indicates downregulation. miRNA, microRNA; DE, differentially expressed.](etm-20-03-2705-g01){#f2-etm-0-0-8991}

![Overall survival analysis using the tool, OncoLnc. Three miRNAs were associated with overall survival in patients with pancreatic cancer. The patients were stratified into high-level and low-level groups. The Figure parts show (A) hsa-miR-126-5p and (B) hsa-miR-3613-5p. miRNA, microRNA.](etm-20-03-2705-g02){#f3-etm-0-0-8991}

![Target gene prediction for hsa-miR-3613-5p. The target genes were predicted using the TargetScan and DIANA-mT online analysis tools. miRNA, microRNA.](etm-20-03-2705-g03){#f4-etm-0-0-8991}

![Functional analyses of the hsa-miR-3613-5p target genes. (A) KEGG pathway network of hsa-miR-3613-5p-overlapping target genes. The diamond represents hsa-miR-3613-5p, whereas the circles represent pathways enriched in overlapping genes. Circles in red denote the overlapping genes. (B) Significantly enriched GO biological processes (P\<0.05) are presented in the pie chart. KEGG, Kyoto Encyclopedia of Genes and Genomes; miR, microRNA; GO, Gene Ontology.](etm-20-03-2705-g04){#f5-etm-0-0-8991}

![Functional analysis of the top 250 genes in GSE62452. The significantly enriched KEGG pathways are shown in the bar chart. Red arrow indicates the location of p53 signaling pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes.](etm-20-03-2705-g05){#f6-etm-0-0-8991}

![Survival analysis and gene expression comparisons in non-cancer and cancer tissues of the CDK6 and RRM2 genes. (A) Overall survival analysis using OncoLnc. (B) Expression of the CDK6 and RRM2 genes in non-cancer and cancer tissues according to immunohistochemistry experiments. CDK6, cyclin-dependent kinase 6; RRM2, ribonucleoside-diphosphate reductase subunit M2.](etm-20-03-2705-g06){#f7-etm-0-0-8991}

###### 

Differentially expressed miRNAs in TCGA.

  A, Upregulated                              
  ------------------ ---------- ------------- --------------
  hsa-miR-892b       1.530606   2.62x10^-5^   5.48x10^-3^
  hsa-miR-194-2      2.544289   2.89x10^-4^   1.89x10^-2^
  hsa-miR-200a       2.161983   3.18x10^-4^   1.92x10^-2^
  hsa-miR-194-1      2.497915   3.98x10^-4^   2.19x10^-2^
  B, Downregulated                            
  miRNA_ID           log~2~FC   P-value       adj.P.Val
  hsa-miR-424        -1.94731   1.00x10^-6^   5.24x10^-4^
  hsa-miR-191        -1.29315   1.88x10^-5^   4.91x10^-3^
  hsa-miR-484        -1.17521   5.37x10^-5^   9.356x10^-3^
  hsa-miR-142        -2.36313   6.35x10^-5^   9.49x10^-3^
  hsa-miR-15b        -1.12279   8.34x10^-5^   1.09x10^-2^
  hsa-miR-450a-1     -1.66695   1.05x10^-4^   1.21x10^-2^
  hsa-miR-423        -1.12274   1.15x10^-4^   1.21x10^-2^
  hsa-miR-126        -1.44387   1.90x10^-4^   1.72x10^-2^
  hsa-miR-505        -1.24908   2.19x10^-4^   1.76x10^-2^
  hsa-miR-16-1       -1.01975   2.46x10^-4^   1.84x10^-2^
  hsa-miR-342        -1.50755   2.86x10^-4^   1.89x10^-2^
  hsa-miR-130a       -1.1491    3.30x10^-4^   1.92x10^-2^
  hsa-miR-3613       -1.44412   5.13x10^-4^   2.55x10^-2^
  hsa-miR-450a-2     -1.55496   5.65x10^-4^   2.69x10^-2^
  hsa-miR-26b        -1.1955    7.51x10^-4^   3.41x10^-2^
  hsa-miR-451        -2.71252   8.47x10^-4^   3.60x10^-2^
  hsa-miR-19b-2      -1.38624   1.01x10^-3^   4.04x10^-2^
  hsa-miR-106a       -1.4397    1.07x10^-3^   4.15x10^-2^
  hsa-miR-503        -1.6143    1.36x10^-3^   4.91x10^-2^

miR, microRNA; TCGA, TCGA, The Cancer Genome Atlas.

###### 

Top 250 miRNAs in the GSE43796 dataset.

  miRNA_ID                                                        log~2~FC   P-value        adj.P.Val
  --------------------------------------------------------------- ---------- -------------- -------------
  hsa-miR-216b                                                    -4.8039    4.65x10^-10^   1.3x10^-6^
  hsa-miR-216a                                                    -5.4037    8.97x10^-10^   1.3x10^-6^
  hsa-miR-216b                                                    -3.716     1.10x10^-9^    1.3x10^-6^
  hsa-miR-216a                                                    -4.8889    1.64x10^-9^    1.44x10^-6^
  hsa-miR-217                                                     -4.4452    2.34x10^-9^    1.44x10^-6^
  hsa-miR-217                                                     -3.8       2.46x10^-9^    1.44x10^-6^
  hsa-miR-216b                                                    -3.169     3.30x10^-9^    1.47x10^-6^
  hsa-miR-216a                                                    -4.0446    3.34x10^-9^    1.47x10^-6^
  hsa-miR-217                                                     -3.1523    1.26x10^-8^    4.94x10^-6^
  hsa-miR-216a                                                    -1.6859    2.2x10^-7^     7.75x10^-5^
  hsa-miR-216b                                                    -0.4224    8.8x10^-7^     0.000282
  hsa-miR-4269                                                    -1.3437    1.64x10^-6^    0.000483
  hsa-miR-217                                                     -1.2283    2.28x10^-6^    0.000618
  hsa-miR-4269                                                    -1.4259    2.49x10^-6^    0.000626
  kshv-miR-K12-8                                                  -1.568     3.17x10^-6^    0.000744
  hsa-miR-564                                                     -1.1939    4.87x10^-6^    0.000963
  hsa-miR-564                                                     -1.2361    5.06x10^-6^    0.000963
  hsa-miR-3616-3p                                                 -0.4127    5.14x10^-6^    0.000963
  hsa-miR-130b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.3289    5.46x10^-6^    0.000963
  hsa-miR-564                                                     -1.1964    5.72x10^-6^    0.000963
  kshv-miR-K12-8                                                  -1.4459    5.74x10^-6^    0.000963
  hsa-miR-1307                                                    0.5635     6.74x10^-6^    0.001079
  hsa-miR-3916                                                    -0.1009    8.93x10^-6^    0.001368
  hsa-miR-320e                                                    0.8174     9.66x10^-6^    0.001419
  hsa-miR-944                                                     -0.1126    1.15x10^-5^    0.001617
  hsa-miR-106b                                                    0.9524     1.39x10^-5^    0.001887
  hsa-miR-148a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.4605    1.6x10^-5^     0.002029
  hsa-miR-130b                                                    -1.9221    1.61x10^-5^    0.002029
  hsa-miR-99b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.1775    1.88x10^-5^    0.002286
  hsa-miR-498                                                     0.4483     1.97x10^-5^    0.002315
  hsa-miR-148a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -1.2935    2.04x10^-5^    0.002316
  hsa-miR-671-3p                                                  0.1226     2.17x10^-5^    0.002391
  hsa-miR-3164                                                    -0.1302    2.84x10^-5^    0.002998
  hsa-miR-548x_v16.0                                              0.1154     2.94x10^-5^    0.002998
  hsa-miR-106b                                                    1.1226     3.02x10^-5^    0.002998
  hsa-miR-320d                                                    0.7308     3.06x10^-5^    0.002998
  hsa-miR-4299                                                    -1.905     3.8x10^-5^     0.003576
  hsa-miR-548o                                                    -0.118     3.86x10^-5^    0.003576
  hsa-miR-93                                                      1.2234     4x10^-5^       0.003611
  hsa-miR-331-3p                                                  1.1039     4.39x10^-5^    0.003864
  hsa-miR-3164                                                    -0.0978    4.61x10^-5^    0.003957
  hsa-miR-130b                                                    -1.6642    4.72x10^-5^    0.003958
  hsa-miR-125a-5p                                                 1.7078     5.11x10^-5^    0.00419
  hsa-miR-29a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       0.9139     5.37x10^-5^    0.004299
  hsa-miR-93a                                                     0.2658     5.75x10^-5^    0.004505
  hsa-miR-299-3p                                                  -0.7055    6.01x10^-5^    0.004604
  hsa-miR-4299                                                    -1.8101    6.2x10^-5^     0.004646
  hsa-miR-195^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.1081    8.79x10^-5^    0.00645
  hsa-miR-210                                                     2.4038     8.99x10^-5^    0.006465
  hsa-miR-151-3p                                                  0.6122     0.000104       0.007232
  hsa-miR-3616-3p                                                 -0.4232    0.000105       0.007232
  hsa-miR-498                                                     0.2281     0.000109       0.007391
  hsa-miR-4307                                                    -0.1549    0.000113       0.007447
  hsa-miR-613                                                     -0.1262    0.000114       0.007447
  hsa-miR-148b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.1138    0.00013        0.008259
  hsa-miR-148a                                                    -2.5367    0.000131       0.008259
  hsa-miR-3145-3p                                                 -0.0763    0.000145       0.008957
  hsa-miR-186                                                     0.713      0.000164       0.009947
  hsa-miR-302b                                                    -0.1691    0.000185       0.011055
  hsa-miR-942                                                     -0.1017    0.000189       0.011107
  hsa-miR-99b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.1313    0.000207       0.011853
  hsa-miR-548l                                                    -0.0957    0.000212       0.011853
  hsa-miR-3681                                                    -0.0908    0.000212       0.011853
  hsa-miR-93a                                                     0.1248     0.00022        0.011853
  hsa-miR-361-5p                                                  0.9421     0.000225       0.011853
  hsa-miR-582-5p                                                  1.6334     0.000227       0.011853
  hsa-miR-3613-5p                                                 -0.1532    0.000231       0.011853
  hsa-miR-3132                                                    -1.3333    0.000231       0.011853
  hsa-miR-553                                                     -0.1416    0.000232       0.011853
  hsa-miR-302b                                                    -0.1588    0.000239       0.011976
  hsa-miR-423-3p                                                  0.3666     0.000241       0.011976
  hcmv-miR-US25-1^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^   -0.1146    0.000247       0.012062
  hsa-miR-548t                                                    -0.1388    0.000262       0.012307
  hsa-miR-521                                                     -0.082     0.000262       0.012307
  hsa-miR-3129-5p                                                 -0.1044    0.000262       0.012307
  hsa-miR-99b                                                     1.5986     0.000267       0.012366
  hsa-miR-105^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.1008    0.000271       0.012399
  hsa-miR-3179                                                    -0.0771    0.000283       0.0128
  hsa-miR-186                                                     0.6795     0.000309       0.013787
  hsa-miR-1306                                                    0.234      0.000317       0.01397
  hsa-miR-1289                                                    -0.0883    0.000328       0.014269
  hsa-miR-579                                                     -0.1067    0.00034        0.014628
  hsa-miR-301a                                                    1.8527     0.00036        0.015276
  hsa-miR-148a                                                    -2.337     0.00037        0.015288
  hsa-miR-103a                                                    1.124      0.000371       0.015288
  ebv-miR-BART13                                                  -0.582     0.000373       0.015288
  hsa-miR-448                                                     -0.1176    0.000381       0.015434
  hsa-miR-299-5p                                                  -1.0644    0.000401       0.015917
  hsa-miR-582-5p                                                  1.5887     0.000402       0.015917
  hsa-miR-634                                                     0.1183     0.000431       0.016744
  hsa-miR-3175                                                    -0.054     0.000433       0.016744
  hsa-miR-148a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.1302    0.00044        0.016859
  hsa-miR-548m                                                    -0.1191    0.000484       0.018165
  hsa-miR-3935                                                    0.1933     0.000485       0.018165
  hsa-miR-591                                                     -0.0909    0.000497       0.018364
  hsa-miR-210                                                     2.3178     0.0005         0.018364
  hsa-miR-556-3p                                                  -0.1154    0.000527       0.019151
  hsa-miR-548j                                                    -0.0797    0.000551       0.01949
  hsa-miR-103a                                                    1.0183     0.000553       0.01949
  hsa-miR-4304                                                    0.1412     0.000553       0.01949
  hsa-miR-30c-2a                                                  -0.4667    0.000577       0.020116
  hsa-miR-2116^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      0.1207     0.000583       0.020146
  hsa-miR-361-3p                                                  0.7409     0.00061        0.020859
  hsa-miR-1537                                                    -0.1087    0.000616       0.020877
  hsa-miR-573                                                     -0.1069    0.00064        0.02121
  hsa-miR-3198                                                    -0.7624    0.000641       0.02121
  hsa-miR-1324                                                    -0.073     0.00065        0.02121
  hsa-miR-99b                                                     1.4301     0.000653       0.02121
  hsa-miR-107                                                     1.058      0.000656       0.02121
  hsa-miR-587                                                     -0.0948    0.000663       0.021248
  hsa-miR-586                                                     -0.0974    0.000686       0.021727
  hsa-miR-325                                                     -0.1108    0.000691       0.021727
  hsa-miR-24                                                      0.9059     0.000705       0.021812
  hsa-miR-128                                                     1.1449     0.000706       0.021812
  hsa-miR-892a                                                    -0.1117    0.000713       0.021833
  hsa-miR-573                                                     -0.109     0.000719       0.021833
  hsa-miR-1265                                                    -0.0783    0.000727       0.021835
  hsa-miR-30c-1^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     -0.3181    0.000731       0.021835
  hsa-miR-183                                                     2.7044     0.000747       0.022129
  hsa-miR-301a                                                    1.8224     0.000771       0.022642
  hsa-miR-193a-3p                                                 -1.5641    0.000797       0.0232
  hsa-miR-125a-5p                                                 1.3715     0.000809       0.023366
  hsa-miR-331-3p                                                  0.8881     0.000839       0.023999
  hsa-miR-3115                                                    -0.0798    0.000845       0.023999
  hsa-let-7d^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^        0.3463     0.000856       0.024136
  hsa-miR-183                                                     2.6632     0.000864       0.024164
  hsa-miR-3180-5p                                                 0.0999     0.000887       0.024611
  hsa-miR-1539                                                    0.0936     0.000898       0.024707
  hsa-miR-1306                                                    0.1827     0.000945       0.025729
  hsa-miR-3142                                                    -0.0824    0.000949       0.025729
  hsa-miR-548d-5p                                                 -0.1196    0.000977       0.026272
  hsa-miR-183                                                     2.5675     0.001          0.026774
  hsa-miR-582-3p                                                  0.5736     0.00102        0.027098
  hsa-miR-569                                                     -0.0898    0.00104        0.027306
  hsa-miR-411                                                     -0.813     0.00106        0.027402
  hsa-miR-3668                                                    -0.0768    0.00107        0.027402
  hsa-miR-320b                                                    0.7204     0.00107        0.027402
  hsa-miR-302f                                                    -0.0959    0.00107        0.027402
  hsa-miR-183^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       1.5187     0.00111        0.02783
  hsa-miR-93                                                      0.9869     0.00112        0.02783
  hsa-miR-182                                                     2.0297     0.00113        0.02783
  hsa-miR-4317                                                    0.7724     0.00113        0.02783
  hsa-miR-544                                                     -0.1508    0.00114        0.02783
  hsa-miR-1179                                                    -0.074     0.00114        0.02783
  hsa-miR-1243                                                    -0.0774    0.00116        0.028001
  hcmv-miR-UL36^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     -0.0762    0.00116        0.028001
  hsa-miR-30a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -1.209     0.00117        0.028137
  hsa-miR-1179                                                    -0.073     0.00123        0.029223
  hsa-miR-3140-3p                                                 -0.1157    0.00124        0.029223
  hsa-miR-1286                                                    0.0726     0.00124        0.029223
  hsa-miR-563                                                     -0.1156    0.00125        0.029223
  hsa-miR-30e                                                     -0.7409    0.00127        0.029223
  ebv-miR-BART8                                                   -0.0971    0.00127        0.029223
  hsa-miR-4307                                                    -0.1001    0.00128        0.029223
  hsa-miR-3158-3p                                                 -0.054     0.00141        0.031927
  hsa-miR-520h                                                    -0.1088    0.00142        0.031927
  hsa-miR-619                                                     -0.0715    0.00142        0.031927
  hsa-miR-30a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.9917    0.00144        0.032039
  hsa-miR-138-2^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     0.1095     0.00148        0.032687
  hsa-miR-182                                                     2.0004     0.00152        0.03353
  hsa-miR-484                                                     0.9217     0.00154        0.033733
  hsa-miR-425                                                     0.8842     0.00157        0.03375
  hsa-miR-4310                                                    0.1418     0.00158        0.03375
  hsa-miR-302c                                                    -0.106     0.00158        0.03375
  hsa-miR-15b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.1306    0.00159        0.03375
  hsa-miR-302f                                                    -0.0859    0.0016         0.03375
  hsa-miR-2053                                                    -0.1115    0.0016         0.03375
  hsa-miR-4291                                                    0.8359     0.00167        0.035042
  hsa-miR-421                                                     0.5925     0.00169        0.035259
  hsa-miR-381                                                     -1.9681    0.00171        0.035396
  hsa-miR-3647-3p                                                 -0.1454    0.00173        0.035724
  hsa-miR-328                                                     0.803      0.00178        0.036488
  hsa-miR-3620                                                    0.1262     0.00185        0.037581
  hsa-miR-3927                                                    -0.0686    0.0019         0.03843
  hsa-miR-92a-2^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     -0.0791    0.00192        0.038565
  hsa-miR-4317                                                    0.3214     0.00193        0.038645
  hsa-miR-149                                                     1.1225     0.00196        0.038946
  hsa-miR-183^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       1.0302     0.00197        0.038946
  hsa-miR-484                                                     1.0961     0.00206        0.040621
  hsa-miR-3198                                                    -0.6895    0.00215        0.041996
  hsa-miR-190b                                                    -0.1413    0.00216        0.041996
  hsa-miR-553                                                     -0.086     0.0022         0.0425
  hsa-miR-324-5p                                                  1.5161     0.00222        0.042666
  hsa-miR-182                                                     2.3243     0.00223        0.042666
  hsa-miR-624^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       0.0748     0.00227        0.04329
  hsa-let-7e                                                      1.2111     0.00233        0.044225
  hsa-miR-30a                                                     -1.6194    0.00241        0.045407
  hsa-miR-181b                                                    1.2205     0.00244        0.045689
  hsa-miR-1294                                                    -0.0642    0.00248        0.046233
  hsa-miR-320a                                                    0.4892     0.00251        0.046444
  hsa-miR-491-5p                                                  0.5918     0.00252        0.046444
  hsa-miR-4293                                                    0.081      0.00253        0.046485
  hsa-miR-345                                                     0.2807     0.00259        0.047307
  hsa-miR-563                                                     0.0935     0.00268        0.048439
  hsa-miR-219-1-3p                                                -0.0921    0.00268        0.048439
  hsa-miR-3924                                                    -0.0974    0.0027         0.048517
  hsa-miR-367^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.0887    0.0028         0.050028
  ebv-miR-BART10^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^    -0.1116    0.00282        0.050028
  hsa-miR-1284                                                    -0.0713    0.00283        0.050028
  hsa-miR-1291                                                    0.1029     0.00286        0.05032
  hsa-miR-608                                                     -0.057     0.00298        0.052183
  hsa-miR-425                                                     0.8292     0.003          0.052407
  hsa-miR-4291                                                    0.9583     0.00315        0.054597
  hsa-miR-19b-2^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     -0.1085    0.00316        0.054597
  hsa-miR-19b-1^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^     0.1263     0.00319        0.054855
  hsa-miR-548u                                                    -0.0593    0.00328        0.056055
  hsv2-miR-H22                                                    -1.2156    0.0033         0.056055
  hsa-miR-374c                                                    0.1584     0.00331        0.056055
  hsa-miR-219-5p                                                  -0.5987    0.00333        0.056055
  hsa-miR-29c^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       1.0172     0.00338        0.056676
  hsa-miR-493^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.7182    0.00339        0.056676
  hsa-miR-302a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      0.0797     0.0035         0.057987
  hsa-miR-130b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.097     0.00351        0.057987
  hsa-miR-651                                                     -0.079     0.00352        0.057987
  hiv1-miR-TAR-3p                                                 0.361      0.00357        0.058286
  hsa-miR-24                                                      0.6936     0.00357        0.058286
  hsa-let-7d^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^        0.2023     0.00363        0.058837
  hsa-miR-140-5p                                                  1.0041     0.00364        0.058837
  hsa-miR-548b-3p                                                 -0.0828    0.00368        0.059172
  hsa-miR-3154                                                    0.31       0.00371        0.059172
  hsa-miR-324-5p                                                  1.3843     0.00372        0.059172
  hsa-miR-33a                                                     0.5461     0.00374        0.059172
  hsa-miR-154                                                     -1.5917    0.00375        0.059172
  hsa-miR-107                                                     0.966      0.00381        0.059939
  hsv2-miR-H22                                                    -1.1749    0.00393        0.061263
  hsa-miR-3649                                                    -0.068     0.00395        0.061263
  hsa-miR-182^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       0.8636     0.00396        0.061263
  hsa-miR-501-3p                                                  0.3569     0.00396        0.061263
  hsa-miR-449b                                                    -0.0656    0.0041         0.062902
  hsa-miR-3942-5p                                                 -0.0792    0.00412        0.062902
  hsa-let-7e                                                      1.2761     0.00412        0.062902
  hcmv-miR-UL22A^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^    -0.0787    0.00421        0.063705
  hsa-miR-3684                                                    -0.0467    0.00426        0.063705
  hsa-miR-585                                                     -0.0906    0.00427        0.063705
  hsa-miR-3606                                                    -0.0616    0.00427        0.063705
  hsa-miR-191                                                     0.2472     0.00428        0.063705
  hsa-miR-18b^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^       -0.0939    0.0043         0.063705
  hsa-miR-4309                                                    -0.056     0.00432        0.063705
  hcmv-miR-UL22A                                                  0.0758     0.00432        0.063705
  hsa-miR-320c                                                    0.6075     0.00444        0.06516
  hsa-miR-942                                                     -0.1076    0.00455        0.066499
  hsa-miR-3190                                                    0.1172     0.00458        0.066689
  hsa-miR-374a^[a](#tfn1-etm-0-0-8991){ref-type="table-fn"}^      -0.0927    0.00461        0.066754
  hsa-miR-3675-3p                                                 0.0965     0.00462        0.066754
  hsa-miR-374c                                                    0.6226     0.00467        0.067088
  hsa-miR-3152-3p                                                 -0.0574    0.00474        0.067654
  hsa-miR-3189-3p                                                 0.1598     0.00474        0.067654
  hsa-miR-29a                                                     0.6544     0.00482        0.067818
  hsa-miR-892a                                                    -0.0808    0.00482        0.067818
  hsa-miR-2355-5p                                                 0.358      0.00483        0.067818

^a^miR with lower expression levels; FC, fold change; miR, microRNA.

[^1]: ^\*^Contributed equally

[^2]: *Abbreviations:* miRNA, microRNAs; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus; DE, differentially expressed; DEGs, differentially expressed genes; FC, fold change; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene ontology; BP, biological process; OS, overall survival; HPA, Human Protein Atlas
